CVE-2026-59501
Received Received - Intake

Improper Access Control in Product

Vulnerability report for CVE-2026-59501, including description, CVSS score, EPSS score, affected products, exploitability, helpful resources, and attack-flow context.

Publication date: 2026-08-13

Last updated on: 2026-08-13

Assigner: Israel National Cyber Directorate

Description

CWE-284: Improper Access Control

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published
2026-08-13
Last Modified
2026-08-13
Generated
2026-08-13
AI Q&A
2026-08-13
EPSS Evaluated
N/A
NVD
EUVD

Affected Vendors & Products

Currently, no data is known.

Helpful Resources

Exploitability

CWE
CWE Icon
KEV
KEV Icon
CWE ID Description
CWE-284 The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

Attack-Flow Graph

AI Quick Actions

Instant insights powered by AI
Executive Summary

This is an improper access control vulnerability (CWE-284) where unauthorized users can access sensitive data or functions due to missing or weak access restrictions. The CVSS score of 8.2 indicates high impact on confidentiality with low impact on integrity and availability.

Impact Analysis

An attacker could exploit this to read sensitive information, modify data, or perform unauthorized actions. The high confidentiality impact (C:H) means personal or sensitive data could be exposed, leading to privacy breaches or data theft.

Compliance Impact

This vulnerability likely violates GDPR (data protection) and HIPAA (health data privacy) due to unauthorized access risks. Non-compliance could result in fines, legal penalties, or reputational damage for organizations handling regulated data.

Chat Assistant

Ask questions about this CVE
Hi! I’m here to help you understand CVE-2026-59501. Ask me anything about the vulnerability, its impact, or mitigation strategies.
0/70

EPSS Chart